Onconetix, Inc. 8-K

What Happened

• On March 18, 2026, Onconetix, Inc. announced that its Board appointed independent director David White as Chief Executive Officer, effective that date. Karina Fedasz will remain with the company as Interim Chief Financial Officer. The company and Mr. White executed an employment agreement (filed as Exhibit 10.1) under which Mr. White will receive a monthly base salary of $21,700 and is bound by confidentiality, non-compete, and non-solicitation covenants.
• On March 19, 2026, director Timothy Ramdeen resigned from the Board and from its Audit, Compensation and Nominating & Corporate Governance Committees, citing no disagreement with management or the Board. That same day the Board appointed Sammy Dorf as a director and as a member of the Audit Committee.

Key Details

• CEO appointment effective: March 18, 2026 (David White).
• CEO pay: $21,700 monthly base salary per the employment agreement.
• Board compensation changes: Karina Fedasz’s monthly compensation reduced by $5,000; Lead Independent Director Andrew Oakley’s monthly compensation reduced by $26,000 (both reductions effective March 18, 2026).
• Board change timing: Timothy Ramdeen resigned effective March 19, 2026; Sammy Dorf appointed effective March 19, 2026 and assigned to the Audit Committee.
• Governance disclosures: Mr. White and Mr. Dorf have no family relationships with current directors/officers and no transactions requiring Item 404(a) disclosure; no selection arrangements were reported.

Why It Matters

• Leadership change: Naming a permanent CEO is a material governance event that can affect company strategy and investor confidence; Mr. White brings extensive executive and board experience that the company highlights as relevant to his role.
• Cost/compensation impact: The Board adjusted director/executive-related cash compensation (reductions totaling $31,000 monthly across two individuals), which slightly lowers near-term cash outflows tied to governance pay.
• Board composition and oversight: The resignation and appointment change the Board and Audit Committee membership—relevant for oversight of financial reporting and governance. The employment agreement is filed as an exhibit, giving investors access to the CEO’s contractual terms.